BR9204542A - Composto,analogos de tri-arg proinsulina,proinsulina clivada,formulacao farmaceutica,e processo para a preparacao de um analogo de tri-arg-insulina humana - Google Patents
Composto,analogos de tri-arg proinsulina,proinsulina clivada,formulacao farmaceutica,e processo para a preparacao de um analogo de tri-arg-insulina humanaInfo
- Publication number
- BR9204542A BR9204542A BR9204542A BR9204542A BR9204542A BR 9204542 A BR9204542 A BR 9204542A BR 9204542 A BR9204542 A BR 9204542A BR 9204542 A BR9204542 A BR 9204542A BR 9204542 A BR9204542 A BR 9204542A
- Authority
- BR
- Brazil
- Prior art keywords
- proinsulin
- arg
- tri
- clived
- compound
- Prior art date
Links
- 108010076181 Proinsulin Proteins 0.000 title 2
- 150000001875 compounds Chemical class 0.000 title 1
- 239000004026 insulin derivative Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Emergency Medicine (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80116391A | 1991-11-26 | 1991-11-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9204542A true BR9204542A (pt) | 1993-06-01 |
Family
ID=25180362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9204542A BR9204542A (pt) | 1991-11-26 | 1992-11-25 | Composto,analogos de tri-arg proinsulina,proinsulina clivada,formulacao farmaceutica,e processo para a preparacao de um analogo de tri-arg-insulina humana |
Country Status (17)
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0815136B1 (en) * | 1995-02-20 | 2007-06-13 | The Walter And Eliza Hall Institute Of Medical Research | Immunoreactive and immunotherapeutic molecules which interact in subjects with insulin-dependent diabetes mellitus (iddm) |
| DK0821006T3 (da) * | 1996-07-26 | 2004-08-16 | Aventis Pharma Gmbh | Insulinderivater med öget zinkbinding |
| US6444641B1 (en) | 1997-10-24 | 2002-09-03 | Eli Lilly Company | Fatty acid-acylated insulin analogs |
| US6933272B1 (en) | 1998-09-22 | 2005-08-23 | Erik Helmerhorst | Use of non-peptidyl compounds for the treatment of insulin related ailments |
| EP1265630B1 (en) | 2000-03-24 | 2006-06-07 | Genentech, Inc. | Use of insulin for the treatment of cartilagenous disorders |
| HUP0700126A2 (en) * | 2001-12-20 | 2007-06-28 | Lilly Co Eli | Insulin molecule having protracted time action |
| EP1620465A2 (en) * | 2003-04-29 | 2006-02-01 | Eli Lilly And Company | Insulin analogs having protracted time action |
| US8343914B2 (en) * | 2006-01-06 | 2013-01-01 | Case Western Reserve University | Fibrillation resistant proteins |
| EP2049149B1 (en) | 2006-07-31 | 2015-04-15 | Novo Nordisk A/S | Pegylated extended insulins |
| DK2074141T3 (en) | 2006-09-22 | 2016-11-28 | Novo Nordisk As | The protease resistant insulin analogues. |
| WO2008043033A2 (en) | 2006-10-04 | 2008-04-10 | Case Western Reserve University | Fibrillation-resistant insulin and insulin analogues |
| JP5496082B2 (ja) | 2007-04-30 | 2014-05-21 | ノボ・ノルデイスク・エー/エス | タンパク質組成物を乾燥させる方法、乾燥タンパク質組成物、及び乾燥タンパク質を含有する薬学的組成物 |
| EP2910569B1 (en) | 2008-03-18 | 2016-10-05 | Novo Nordisk A/S | Protease stabilized, acylated insulin analogues |
| WO2009129250A2 (en) * | 2008-04-14 | 2009-10-22 | Case Western Reserve University | Meal-time insulin analogues of enhanced stability |
| MX2010011329A (es) * | 2008-04-22 | 2011-03-15 | Univ Case Western Reserve | Analogos de insulina especificos de isoforma. |
| KR20120129875A (ko) | 2008-07-31 | 2012-11-28 | 케이스 웨스턴 리저브 유니버시티 | 염소화 아미노산을 갖는 인슐린 유사체 |
| US9200053B2 (en) | 2008-07-31 | 2015-12-01 | Case Western Reserve University | Insulin analogues containing penta-fluoro-Phenylalanine at position B24 |
| US8399407B2 (en) * | 2009-09-17 | 2013-03-19 | Case Western Reserve University | Non-standard insulin analogues |
| MX2012006568A (es) | 2009-12-11 | 2012-12-17 | Univ Case Western Reserve | Analogos de insulina con aminoacidos clorados. |
| US9187547B2 (en) * | 2011-03-15 | 2015-11-17 | Novo Nordisk A/S | Human insulin analogues and derivatives comprising cysteine substitutions |
| BR112014025132A2 (pt) | 2012-04-11 | 2017-07-11 | Novo Nordisk As | formulações de insulina |
| CA2926701A1 (en) | 2013-10-07 | 2015-04-16 | Novo Nordisk A/S | Novel derivative of an insulin analogue |
| CN104017809A (zh) * | 2014-06-05 | 2014-09-03 | 山东省农业科学院生物技术研究中心 | 改造的人Insulin蛋白表达基因及表达方法 |
| AU2015328222B9 (en) | 2014-10-06 | 2020-12-24 | Case Western Reserve University | Biphasic single-chain insulin analogues |
| CA2979397A1 (en) * | 2015-03-12 | 2016-09-15 | Board Of Trustees Of Michigan State University | Compositions and methods for measuring c-peptide binding and diagnosing immune-mediated diseases |
| CN108473548A (zh) * | 2015-09-24 | 2018-08-31 | 韩美药品股份有限公司 | 胰岛素生产方法 |
| SI3554534T1 (sl) | 2016-12-16 | 2021-09-30 | Novo Nordisk A/S | Farmacevtski sestavki, ki vsebujejo inzulin |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3326473A1 (de) * | 1983-07-22 | 1985-01-31 | Hoechst Ag, 6230 Frankfurt | Pharmazeutisches mittel zur behandlung des diabetes mellitus |
| DE3326472A1 (de) * | 1983-07-22 | 1985-02-14 | Hoechst Ag, 6230 Frankfurt | Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus |
| US4581165A (en) * | 1984-06-14 | 1986-04-08 | Eli Lilly And Company | Anti-diabetic compounds |
| US4569791A (en) * | 1984-06-14 | 1986-02-11 | Eli Lilly And Company | Anti-diabetic compounds |
| US4569792A (en) * | 1984-06-14 | 1986-02-11 | Eli Lilly And Company | Anti-diabetic compounds |
| US5008241A (en) * | 1985-03-12 | 1991-04-16 | Novo Nordisk A/S | Novel insulin peptides |
| DK129385A (da) * | 1985-03-22 | 1986-09-23 | Novo Industri As | Peptider og fremstilling deraf |
| IL84110A (en) * | 1986-10-14 | 1992-11-15 | Lilly Co Eli | Process for transforming a human insulin precursor to a human insulin |
| US4992418A (en) * | 1987-07-17 | 1991-02-12 | Mount Sinai School Of Medicine | Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin |
| ATE101620T1 (de) * | 1988-06-23 | 1994-03-15 | Hoechst Ag | Mini-proinsulin, seine herstellung und verwendung. |
| DE3844211A1 (de) * | 1988-12-29 | 1990-07-05 | Hoechst Ag | Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung |
| DK134189D0 (da) * | 1989-03-20 | 1989-03-20 | Nordisk Gentofte | Insulinforbindelser |
| DE3936876A1 (de) * | 1989-11-06 | 1991-05-23 | Hoechst Ag | Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung |
| US5130236A (en) * | 1989-12-07 | 1992-07-14 | Eli Lilly And Company | Process for producing des(64,65)-proinsulin |
| US5139716A (en) * | 1990-02-20 | 1992-08-18 | Loral Aerospace Corp. | Method of fabricating coolable ceramic structures |
-
1992
- 1992-11-18 TW TW081109247A patent/TW224471B/zh active
- 1992-11-18 NZ NZ24517092A patent/NZ245170A/xx unknown
- 1992-11-18 ZA ZA928916A patent/ZA928916B/xx unknown
- 1992-11-18 CZ CS923424A patent/CZ342492A3/cs unknown
- 1992-11-19 CA CA002083360A patent/CA2083360A1/en not_active Abandoned
- 1992-11-20 EP EP92310616A patent/EP0544466A1/en not_active Withdrawn
- 1992-11-23 IL IL103849A patent/IL103849A0/xx unknown
- 1992-11-23 MX MX9206724A patent/MX9206724A/es unknown
- 1992-11-24 NO NO92924525A patent/NO924525L/no unknown
- 1992-11-24 KR KR1019920022175A patent/KR930009591A/ko not_active Withdrawn
- 1992-11-24 HU HU9203688A patent/HUT63457A/hu unknown
- 1992-11-24 AU AU28576/92A patent/AU2857692A/en not_active Abandoned
- 1992-11-24 HU HU9203688A patent/HU9203688D0/hu unknown
- 1992-11-25 FI FI925343A patent/FI925343L/fi not_active Application Discontinuation
- 1992-11-25 BR BR9204542A patent/BR9204542A/pt not_active Application Discontinuation
- 1992-11-25 CN CN92113309A patent/CN1072723A/zh active Pending
- 1992-11-25 JP JP31483692A patent/JP3304442B2/ja not_active Expired - Fee Related
-
1993
- 1993-07-06 US US08/087,831 patent/US5491216A/en not_active Expired - Fee Related
-
1995
- 1995-06-06 US US08/466,945 patent/US5698669A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| NZ245170A (en) | 1994-07-26 |
| HU9203688D0 (en) | 1993-03-29 |
| FI925343A0 (fi) | 1992-11-25 |
| US5491216A (en) | 1996-02-13 |
| JPH05286998A (ja) | 1993-11-02 |
| IL103849A0 (en) | 1993-04-04 |
| EP0544466A1 (en) | 1993-06-02 |
| FI925343A7 (fi) | 1993-05-27 |
| HUT63457A (en) | 1993-08-30 |
| ZA928916B (en) | 1994-05-18 |
| CA2083360A1 (en) | 1993-05-27 |
| CN1072723A (zh) | 1993-06-02 |
| NO924525D0 (no) | 1992-11-24 |
| AU2857692A (en) | 1993-05-27 |
| MX9206724A (es) | 1993-05-01 |
| JP3304442B2 (ja) | 2002-07-22 |
| FI925343L (fi) | 1993-05-27 |
| US5698669A (en) | 1997-12-16 |
| NO924525L (no) | 1993-05-27 |
| KR930009591A (ko) | 1993-06-21 |
| CZ342492A3 (en) | 1993-06-16 |
| TW224471B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1994-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9204542A (pt) | Composto,analogos de tri-arg proinsulina,proinsulina clivada,formulacao farmaceutica,e processo para a preparacao de um analogo de tri-arg-insulina humana | |
| PT91731A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo ciclosporinas | |
| BR1100850A (pt) | Composto, processo para a preparação de um composto, e, composição farmacêutica | |
| MX9204583A (es) | Analogos de insulina humana y procedimiento para su preparacion. | |
| BR9202002A (pt) | Composto quimico de acido carboxilico,composicao farmaceutica,processo para preparacao de um composto,e,uso deste composto | |
| BR9503812A (pt) | Composto composição farmacêutica utilização método de tratamento de um ser humano processo para a preparação de um composto | |
| BR9100435A (pt) | Composto,composicao farmaceutica,uso,metodo de tratamento de um animal,processos para a preparacao da um composto e de uma composicao farmaceutica | |
| PT84416B (pt) | Processo para a preparacao de formas de dosagem de libertacao controlada para administracao oral contendo polissacaridos de origem natural | |
| BR9600821A (pt) | Composto formulação farmacêutica e processo para a preparação de um composto | |
| BR9204361A (pt) | Composto e processo para sua preparacao formulacao farmaceutica e intermediario | |
| PT87958A (pt) | Processo para a preparacao de composicoes farmaceuticas, contendo antagonistas 5ht-3 | |
| BR9202522A (pt) | Composto,formulacao farmaceutica e processo para preparar um composto | |
| BR1100323A (pt) | Composto, uso de um composto, composição farmacêutica e processo para preparar um composto | |
| PT83508B (pt) | Processo para a preparacao de composicoes farmaceuticas de accao prolongada | |
| IT1240360B (it) | Uso di un derivato dell'1alfa-idrossivitamina d per la preparazione di un medicamento per il trattamento dell' iperparatiroidismo | |
| PT88225A (pt) | Processo para a preparacao de formulacoes farmaceuticas contendo di-hidropiridinas | |
| BR9103036A (pt) | Composto,formulacao farmaceutica e processo para a preparacao do composto | |
| BR9301342A (pt) | Composto,formulacao e composicao farmaceutica,processo para preparar um composto | |
| BR8701121A (pt) | Processo para a preparacao de um composto e processo para combate a pestes | |
| PT90888A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo prostaglandinas | |
| PT90224A (pt) | Processo para a preparacao de composicoes sinergicas contendo imazalilo | |
| MX14533A (es) | Procedimiento para la preparacion de compuestos farmaceuticos | |
| BR8904400A (pt) | Processo para a preparacao de uma formulacao pesticida | |
| BR9406924A (pt) | Composto processo para preparar o mesmo formulaçao farmaceutica e uso de um composto | |
| FI903214A7 (fi) | Naftyyliamino- ja naftyylioksi-pyrimidiinit ja niihin liittyvät yhdisteet, menetelmä niiden valmistamiseksi ja niiden käyttö dermatologisinalääkeaineina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA1 | Application withdrawn (art. 18(2)) | ||
| B15K | Others concerning applications: alteration of classification |
Ipc: C07K 14/62 (2006.01), A61K 38/00 (2006.0 |